Abstract:Objective To investigate the effect of different doses of kinesin superfamily protein 17 (KIF17) antisense oligodeoxy nucleotide on a mouse model of bone cancer pain.Methods Fifty-five C3H/HeJ mice,4-6 weeks of age,weighting 20 g～25 g,were randomly divided into two groups:bone cancer pain group (group A,n=41) and sham operation group (group S,n=14).Group A was induced by implantation of 20 μl α-minimal essence medium (α-MEM) which containing 2×105 osteosarcoma (NCTC 2472) cells into the intramedullary space of the right femur.And 20 μl α-MEM with no cancer cell was injected instead to group S.The number of spontaneous flinches (NSF) and the paw withdrawal mechanical threshold (PWMT) were measured at the day before inoculation (base) and the day 4,7,10 and 14 after inoculation.According to the corresponding time points,ten mice were sacrificed,and the lumbar segment of spinal cord(L3-5) was removed for determination the expression of KIF17 using Western blot.At the day 14 after inoculation,the mice of group A were randomly divided into four groups,KIF17 antisense oligodeoxy nucleotide 2.5,5.0,10.0 μg group (group A1-group A3) and the control group (group Ac).Each group had nine mice.group A1-group A3 were treated by intrathecal injection the corresponding dose of KIF17 antisense oligodeoxy nucleotide group S and group AC was treated by saline.The volume of all drugs was 5 μl.The pain behaviors were measured at 2,12,24,36 h and 48 h after administration and determinated the expression of KIF17.Results Compared with group S [(2.15±0.49),(1.80±0.39) g] and the base[(2.08±0.34),(1.88±0.35) g],the NSF[(11.95±0.78)] was significantly increased and PWMT[(0.34±0.11) g] was decreased at 14 d after inoculation in the bone caner pain groups(P＜0.05),the expression of KIF17 were increased,compared with group AC,the NSF [2 h (4.80±0.40)] was decreased and the PWMT [2 h (0.95±0.33) g] was increased at 2,12,24 h after administration in group A1 (P＜0.05),and the NSF[2 h(2.35±0.26),(2.53±0.21)] was decreased and the PWMT[2 h(1.70±0.32),(1.73±0.40) g] was increased at 2,12,24,36 h after administration in group A2-group A3,group A2 compared with group A3,the NSF and PWMT were no statistically significant difference (P＞0.05),after intrathecal administration,the expression of KIF17 was reduced in group A1-group A3 (P＜0.05).Conclusions Intrathecal KIF17 antisense oligodeoxy nucleotide in the mice of bone cancer pain improve the pain behaviors,and the analgesic effect is time-and dose-related.

The Cyclic AMP Response Element-Binding Protein Antisense Oligonucleotide Induced Anti-Nociception and Decreased the Expression of KIF17 in Spinal Cord after Peripheral Nerve Injury in Mice.

Intrathecal Administration of Cyclic AMP Response Element-Binding Protein-Antisense Oligonucleotide Attenuates Neuropathic Pain after Peripheral Nerve Injury and Decreases the Expression of N-methyl-D-aspartic Receptors in Mice.

Effects of Repeated Intrathecal CREB Antisense Oligodeoxynucleotide on the Expression of NR2A in Spinal Cord in a Mouse Model of Neuropathic Pain

Effects of Ghrelin on Pgsk-3Β and Β-Catenin Expression when Protects Against Neuropathic Pain Behavior in Rats Challenged with Chronic Constriction Injury

Effects of Intrathecally CREB Antisense Oligodeoxynucleotide on Pain Behaviors in a Mouse Model of Chronic Constriction Injury of Sciatic Nerve

Pulsed Radiofrequency to the Dorsal Root Ganglion or the Sciatic Nerve Reduces Neuropathic Pain Behavior, Decreases Peripheral Pro-Inflammatory Cytokines and Spinal Β-Catenin in Chronic Constriction Injury Rats

Effects of Repeated Intrathecally KIF17 Antisense Oligodeoxynucleotide on the Expression of Mlin10 and NR2B in Spinal Cord in a Mouse Model of Bone Cancer Pain

Alleviating Neuropathic Pain Hypersensitivity by Inhibiting PKMζ in the Anterior Cingulate Cortex

The Role Of Ca2+/Calmodulin-Dependent Protein Kinase Ii-Cyclic Amp-Responsive Element Binding Protein Signaling Pathway On Sensory-Discriminative And Affective-Motivational Pain Responses In A Rat Model Of Chronic Constriction Injury Of Sciatic Nerve

Repurposing cell growth-regulating compounds identifies kenpaullone which ameliorates pathologic pain via normalization of inhibitory neurotransmission

CREB-regulated Transcription Coactivator 1 Enhances CREB-dependent Gene Expression in Spinal Cord to Maintain the Bone Cancer Pain in Mice.

The Role of NR2B-CREB-miR212/132-CRTC1-CREB Signal Network in Pain Regulation In Vitro and In Vivo.

Early intervention of ERK activation in the spinal cord can block initiation of peripheral nerve injury-induced neuropathic pain in rats.

Repurposing Cancer Drugs Identifies Kenpaullone Which Ameliorates Pathologic Pain in Preclinical Models Via Normalization of Inhibitory Neurotransmission.

Pi3k Contributed To Modulation Of Spinal Nociceptive Information Related To Ephrinbs/Ephbs

The Utility of Peripherally Restricted Kappa-Opioid Receptor Agonists for Inhibiting Below-Level Pain after Spinal Cord Injury in Mice

Effect of Spirocyclopiperazinium Salt Compound LXM-15 on Spinal Nerve Injury in Rats

PCC0208009, an indirect IDO1 inhibitor, alleviates neuropathic pain and co-morbidities by regulating synaptic plasticity of ACC and amygdala

CBP Expression Contributes to Neuropathic Pain via CREB and MeCP2 Regulation in the Spared Nerve Injury Rat Model

Effect of intrathecal different dose of kinesin superfamily 17 on the development of bone cancer pain in mice

Blocking the Spinal Fbxo3/CARM1/K+ Channel Epigenetic Silencing Pathway as a Strategy for Neuropathic Pain Relief